n-methyl-3,4-methylenedioxyamphetamine has been researched along with Cognitive Decline in 5 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In turn, new hypotheses suggest that Alzheimer's disease (AD) may be promoted by neural stressors." | 1.51 | Effects of MDMA on neuroplasticity, amyloid burden and phospho-tau expression in APPswe/PS1dE9 mice. ( Abad, S; Camarasa, J; Camins, A; Escubedo, E; Folch, J; López-Arnau, R; Pubill, D; Ramon-Duaso, C, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eslami, SM | 1 |
| Khorshidi, L | 1 |
| Ghasemi, M | 1 |
| Rashidian, A | 1 |
| Mirghazanfari, M | 1 |
| Nezhadi, A | 1 |
| Chamanara, M | 1 |
| Mirjani, R | 1 |
| Parrott, AC | 1 |
| Downey, LA | 1 |
| Roberts, CA | 1 |
| Montgomery, C | 1 |
| Bruno, R | 1 |
| Fox, HC | 1 |
| Abad, S | 1 |
| Ramon-Duaso, C | 1 |
| López-Arnau, R | 1 |
| Folch, J | 1 |
| Pubill, D | 1 |
| Camarasa, J | 1 |
| Camins, A | 1 |
| Escubedo, E | 1 |
| Lappin, JM | 1 |
| Sara, GE | 1 |
| Taghizadeh, G | 1 |
| Pourahmad, J | 1 |
| Mehdizadeh, H | 1 |
| Foroumadi, A | 1 |
| Torkaman-Boutorabi, A | 1 |
| Hassani, S | 1 |
| Naserzadeh, P | 1 |
| Shariatmadari, R | 1 |
| Gholami, M | 1 |
| Rouini, MR | 1 |
| Sharifzadeh, M | 1 |
2 reviews available for n-methyl-3,4-methylenedioxyamphetamine and Cognitive Decline
| Article | Year |
|---|---|
Recreational 3,4-methylenedioxymethamphetamine or 'ecstasy': Current perspective and future research prospects.
Topics: Biomedical Research; Cognitive Dysfunction; Fetal Development; Humans; Illicit Drugs; Memory Disorde | 2017 |
Psychostimulant use and the brain.
Topics: Amphetamine; Amphetamine-Related Disorders; Brain; Central Nervous System Stimulants; Cocaine; Cocai | 2019 |
3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Cognitive Decline
| Article | Year |
|---|---|
Protective effects of atorvastatin and rosuvastatin on 3,4-methylenedioxymethamphetamine (MDMA)-induced spatial learning and memory impairment.
Topics: Animals; Apoptosis; Atorvastatin; Cognitive Dysfunction; Dose-Response Relationship, Drug; Hippocamp | 2021 |
Effects of MDMA on neuroplasticity, amyloid burden and phospho-tau expression in APPswe/PS1dE9 mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cognitive Dysfunction; Disease Models, Ani | 2019 |
Protective effects of physical exercise on MDMA-induced cognitive and mitochondrial impairment.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Brain; Cognitive Dysfunction; Cytochromes c; | 2016 |